Le Lézard
Classified in: Oil industry, Business
Subject: TNM

ArcLight Capital Acquires Interest in Deepwater Perdido Platform from BP


BOSTON, Jan. 3, 2018 /PRNewswire/ -- ArcLight Capital Partners announced today that one of its affiliates has acquired a 26.5% non-operated interest in the Perdido Regional Host from BP Exploration & Production Inc. The Perdido Regional Host is the only deepwater production facility serving the Gulf of Mexico's Perdido Foldbelt Trend, one of the most prolific and strategic plays in the Gulf of Mexico.   

The facility, which is operated by Shell Offshore Inc., is an offshore spar moored in southern Alaminos Canyon in approximately 8,000 feet of water, located approximately six miles from the US/Mexican maritime border and 220 miles south of Galveston, Texas. 

"We are very pleased to complete another transaction with BP, our third in the last six months," said Dan Revers, Managing Partner and Founder of ArcLight.  "This investment in Perdido is a continuation of our strategy of identifying and executing quality investment opportunities in the deepwater Gulf of Mexico.  Perdido represents a world class infrastructure asset supported by strong, predictable cash flows from supermajor counterparties producing from established fields."

About ArcLight

ArcLight is one of the leading private equity firms focused on energy infrastructure investments. Founded in 2001, the firm helped pioneer an asset-based private equity approach to investing in the dynamic energy sector. ArcLight has invested over $19 billion in over 100 transactions since inception. Based in Boston, the firm's investment team employs a hands-on value creation strategy that utilizes its in-house technical, operational, and commercial specialists as well as the firm's 850-person asset management affiliate. More information about ArcLight, and a complete list of ArcLight's portfolio companies, can be found at www.arclightcapital.com.

SOURCE ArcLight Capital Partners


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:39
Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New...

at 20:15
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...

at 19:35
Regenx Tech Corp., (the "Company" or "Regenx") is providing this bi-weekly update on the status of the application to the Alberta Securities Commission for a management cease trade order, under National Policy 12-203 -?? Management Cease Trade...

at 19:14
Kadestone Capital Corp. ("Kadestone" or the "Company") , a vertically integrated property company today announced its financial results for the year ended December 31, 2023....

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...



News published on and distributed by: